Indeed, recent evidence suggests that pretangle tau, including its oligomer form, may exhibit greater toxicity than fully formed NFTs (Brunden et al., 2008; Congdon & Duff, 2008; Spires‐Jones & Hyman, 2014), making it an attractive target for therapeutic interventions aimed at preventing AD progression. The gene discussed is MAPT; the disease is Alzheimer disease.